| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/30/1996 | US5512270 Respiratory system disorders, parkinson's disease, gastrointestinal disorders |
| 04/30/1996 | CA1338287C Hetrazepines and processes for preparing them |
| 04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | WO1996011916A1 Azole derivative |
| 04/25/1996 | WO1996011914A1 New carboxylic acid derivatives, their preparation and their use |
| 04/25/1996 | WO1996011911A1 5-lipoxygenase inhibitors |
| 04/25/1996 | WO1996011688A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | CA2202630A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis |
| 04/25/1996 | CA2202623A1 Azole derivative |
| 04/24/1996 | EP0708104A1 Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
| 04/24/1996 | EP0708103A1 Process for the preparation of a tetrazole derivative in two crystalline forms and a new crystalline form of this derivative |
| 04/24/1996 | EP0708088A1 Alkyl-5-methylsulphonyl-benzoyl-guanidine derivatives |
| 04/24/1996 | EP0707586A1 Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 04/24/1996 | EP0707584A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
| 04/24/1996 | EP0707583A1 Process for the preparation of thiopyrans |
| 04/24/1996 | EP0707577A1 Heme binding compounds and use thereof |
| 04/24/1996 | EP0707574A1 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives |
| 04/24/1996 | EP0707573A1 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
| 04/24/1996 | EP0707571A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 04/24/1996 | EP0707490A1 Neuropeptide y antagonists and agonists |
| 04/24/1996 | EP0707475A1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 04/24/1996 | EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 04/24/1996 | EP0450097B1 Benzoheterocyclic compounds |
| 04/24/1996 | CN1121344A New compounds |
| 04/24/1996 | CN1121072A Acetamides |
| 04/24/1996 | CN1031642C Process for preparing of 6-substituted purinyl piperazine derivatives |
| 04/24/1996 | CN1031641C Process for preparing 8-substituted xanthine |
| 04/23/1996 | US5510504 Esterifying amino-protected bis/aminomethyl/phosphinic acid, removing protective groups, reacting with imine or ketone, reacting with base and alkylating agent, treating with acid |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510464 Administration of low dose hemoglobin to increase perfusion |
| 04/23/1996 | US5510365 Suppression of tumor necrosis factor (tnfalpha) activity |
| 04/23/1996 | US5510352 Reducing side effects by administering optically pure isomer |
| 04/23/1996 | US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders |
| 04/23/1996 | US5510345 Biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 04/23/1996 | US5510342 Method of lowering cholesterol |
| 04/23/1996 | US5510340 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/23/1996 | US5510335 Pre-exercise hydration with a glycerol solution |
| 04/23/1996 | US5510331 Antihypertensive peptides |
| 04/23/1996 | US5510330 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| 04/23/1996 | CA2161072A1 Alkyl-5-methylsulfonylbenzoylguanidine derivatives |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996010910A1 Method and formulation of stimulating nitric oxide synthesis |
| 04/18/1996 | DE19533023A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0707006A1 Aroyl-piperidine derivatives |
| 04/17/1996 | EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 04/17/1996 | EP0706532A1 New compound and its preparation |
| 04/17/1996 | EP0706525A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 04/17/1996 | EP0706508A1 Anti-atherosclerotic diaryl compounds |
| 04/17/1996 | EP0706396A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
| 04/17/1996 | EP0536329B1 R(+)-terazosin |
| 04/17/1996 | CN1120844A Phosphonomethyldipeptides |
| 04/17/1996 | CN1120838A Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 04/17/1996 | CN1120538A 3-heteroaliphatyl- and 3-hetero (aryl) aliphatyl-2(1H)-quinolone dericatives |
| 04/17/1996 | CN1120537A Novel substituted sulphonic acid amide, preparation and pharmaceutical composition of same |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/17/1996 | CN1031564C Process for preparation of 4-|-(2-hydroxy-2-phenylethylamino)ethoxy¨ phenyl acet acid and its derivatives |
| 04/16/1996 | US5508419 Substituted triazoles as angiotensin II inhibitors |
| 04/16/1996 | US5508406 For treating cardiovascular disorders |
| 04/16/1996 | US5508305 2, 4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 04/16/1996 | US5508300 Inhibit phosphodiesterase and production of tumor necrosis factor; treating inflammatory diseases |
| 04/16/1996 | US5508299 Angiotensin converting enzyme inhibitor, arterial hypotensive agent; cardiovascular disorders |
| 04/16/1996 | US5508297 Vascular hypertrophy suppression treatment |
| 04/16/1996 | US5508290 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508285 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508279 Increases urine flow while avoiding hypotensive effects |
| 04/16/1996 | US5508275 Lipid-selective antioxidants and their preparation and use |
| 04/16/1996 | US5508272 Compounds containing a fused bicycle ring and processes therefor |
| 04/16/1996 | US5508044 Controlled release form and hydrochlorothiazide immediate release form; treatment of hypertension |
| 04/11/1996 | WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 04/11/1996 | WO1996010574A1 Method for preparing concentrated biologically active silicon compounds |
| 04/11/1996 | WO1996010572A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
| 04/11/1996 | WO1996010571A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES |
| 04/11/1996 | WO1996010559A1 Urea derivatives and their use as acat-inhibitors |
| 04/11/1996 | WO1996010407A1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| 04/11/1996 | CA2200981A1 Urea derivatives and their use as acat-inhibitors |
| 04/11/1996 | CA2200358A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705835A1 Quinoxalic-2,3-diones with an oxa or thiaheterocyclic fused ring |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705831A2 Cycloalkano-indole- and -azaindole derivatives |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0705820A1 6-Amino-nicotinic acid derivatives and their use as selective K-channel modulators |
| 04/10/1996 | EP0705819A1 1,4-Dihydropyridin-3,5-dicarboxylates and their use as selective K-channel modulators |
| 04/10/1996 | EP0705816A1 Benzene derivative useful for ischemic diseases |
| 04/10/1996 | EP0705266A1 Process for producing imidazole derivative |
| 04/10/1996 | EP0705261A1 Antiproliferative naphthyridines |
| 04/10/1996 | EP0705257A1 Aminoacid derivatives as no synthase inhibitors |
| 04/10/1996 | EP0705255A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 04/10/1996 | EP0705244A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 04/10/1996 | EP0705103A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments |
| 04/10/1996 | EP0705100A1 Therapeutic substituted guanidines |
| 04/10/1996 | EP0543919B1 Use of heterocyclic amino-alcohol compounds in the manufacture of a medicament for treatment of cns diseases |